Endologix to Present at Suntrust Robinson Humphrey 36th Annual Institutional Conference
April 04 2007 - 4:00AM
Business Wire
Endologix, Inc. (Nasdaq: ELGX) today announced that Paul McCormick,
president and chief executive officer, will make a presentation to
the investment community at the Suntrust Robinson Humphrey 36th
Annual Institutional Conference on Tuesday, April 10, 2007 at 3:55
p.m. Eastern time (12:55 p.m. Pacific time) at the Ritz-Carlton
Buckhead Hotel in Atlanta. Interested investors may gain access to
a live audio webcast and slide presentation via the Internet by
visiting the Company�s Web site at www.endologix.com. Please go to
the Interviews/Presentations page on the Investor Relations section
of the Web site. The presentation will be available and archived on
the Web site for 30 days. About Endologix Endologix, Inc. develops
and manufactures minimally invasive treatments for vascular
diseases. Endologix's Powerlink System is an endoluminal stent
graft (ELG) for treating abdominal aortic aneurysms (AAA). AAA is a
weakening of the wall of the aorta, the largest artery in the body,
resulting in a balloon-like enlargement. Once AAA develops, it
continues to enlarge and, if left untreated, becomes increasingly
susceptible to rupture. The overall patient mortality rate for
ruptured AAA is approximately 75%, making it the thirteenth leading
cause of death in the U.S. Additional information can be found on
Endologix�s Web site at www.endologix.com.
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Sep 2024 to Oct 2024
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Oct 2023 to Oct 2024